Abstract
Shifting Perceptions of CRISPR
Highlights
More than 20 cell and gene therapies are available to safely minimize genetic diseases such as retinal dystrophy (LUXTURNA), some B-cell lymphomas (YESCARTA), and B-cell lymphoblastic leukemia (KYMRIAH).[1]
Amid the COVID-19 pandemic, the broad potential applications of Clustered Regular Inter Spaced Palindromic Repeats (CRISPR) have extended beyond gene editing
CRISPR is being used in rapid diagnostic testing to determine whether an individual becomes infected with SARS-Cov-2 and the specific variant.[4]
Summary
Perceptions about gene editing have fluctuated, especially since the 1970s. Support has varied for recombinant DNA in which editing a bacterial genome produces human insulin to treat diabetes, genetically modified plants such as antibiotic resistant tobacco, and other genetically modified organisms. Human gene editing has a tainted past: consider the teenager Jesse Gelsinger who tragically died in a gene therapy clinical trial in 1999.6 Another gene therapy trial led to the development of leukemia in several young children.[7] In the last two decades, there have been significant improvements in safety and reliability. Though scientists have developed various gene therapies over the years, such as viral vector delivery of therapeutic transgenes, transcription activator-like effector nucleases (TALENS), and zinc finger nucleotides, CRISPR far surpasses them by safety, accuracy, and ease of use.[8]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.